Profarma Distribuidora de Produtos Farmaceuticos PFRM3.SA · BRL
Health Care · B3 · 🇧🇷 Brazil
7.22
+2.12%
Close of 9 Nov 2026, in BRL
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Profarma Distribuidora de Produtos Farmaceuticos
Its shares trade on B3 under the ticker PFRM3.SA. It has been listed since 26 October 2006. In the fiscal year to 31 December 2025, it reported revenue of BRL 11.45bn and net income of BRL 118.9m. At that date it held total assets of BRL 6.23bn and shareholders' equity of BRL 1.35bn.
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. The company is headquartered in Rio De Janeiro, Rio De Janeiro. The company went IPO on 2006-10-26. The firm's activities are divided into two segments: Pharmaceutical Distribution and Retail. The Pharmaceutical Distribution division is responsible for the wholesale of medicines and personal care and beauty products to pharmaceutical retailers. The Retail division focuses on the management of a pharmacies network under a number of brand names, such as Drogasmil and Tamoio. Its products range includes prescription drugs, over-the-counter (OTC) generics, personal hygiene articles and cosmetics, vaccines, dermatological products and hospital pharmaceuticals, among others. The firm's subsidiaries include Farmadacta Informatica Ltda, Promovendas Representacoes Ltda, Interagile Propaganda e Promocoes Ltda and Locafarma Solucoes de Transportes e Logistica Ltda, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 26 Oct 2006
- Employees
- 7,077
- Website
- profarma.com.br ↗
Leadership
Pay as last reported
- Sammy BirmarckerChairman of the Board, Chief Executive Officer, Member of the Executive Board, since 1986
- Manoel BirmarckerVice Chairman of the Board, since 2008
- Maximiliano Guimaraes FischerChief Financial Officer, Investor Relations Officer, Member of the Executive Board
- Armando Sereno Diogenes MartinsDirector
- Mr. Dan IoschpeIndependent Director
- Fernando PerroneIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company has 7077 employees
- Operates in the Health Care sector with a focus on pharmaceutical distribution
- Has a diversified product range including prescription drugs and OTC generics
Weaknesses
- No specific weaknesses mentioned in the provided information
- No details on financial performance or market share provided
- No information on competitive disadvantages
Opportunities
- Expansion of pharmaceutical distribution to new markets
- Growth potential in the retail pharmacy network under brands like Drogasmil
- Potential for increased sales of personal care and beauty products
Threats
- Dependence on the pharmaceutical industry which may face regulatory changes
- Competition from other pharmaceutical distributors
- Potential market saturation in the retail pharmacy segment
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.